Seth Ahlquist

Seth Ahlquist

Auto-generated profile, based on publicly available information

Seth Ahlquist

Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Santa Monica, CA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2022 in Arthroplasty Today
Verified
Journal Article
Open access
AUAlexander Upfill-Brown
Alexander Upfill-Brown
PHPeter P. Hsiue
Peter P. Hsiue
TSTroy Sekimura
Troy Sekimura
BSBrendan Shi
Brendan Shi
SASeth A. Ahlquist
Seth A. Ahlquist
ASAlexandra I. Stavrakis
Alexandra I. Stavrakis
As primary total knee arthroplasty volume continues to increase, so will the number of revision total knee arthroplasty (rTKA) procedures. The purpose of this study is to provide an updated perspective on the incidence, indications, and financial burden of rTKA in the United States. This was a retrospective epidemiologic analysis using the National Inpatient Sample. International Classification of Diseases ninth and tenth revision codes were used to identify patients who underwent rTKA and create cohorts based on rTKA indications from 2012 to 2019. National and regional trends for length of stay, cost, and discharge location were evaluated. A total of 505,160 rTKA procedures were identified. The annual number of rTKA procedures increased by 29.6% over the study period (56,490 to 73,205). The top 3 indications for rTKA were aseptic loosening (23.1%), periprosthetic joint infection (PJI) (20.4%), and instability (11.0%). Over the study period, the proportion of patients discharged to skilled nursing facility decreased from 31.7% to 24.1% (P < .001). Hospital length of stay decreased from 4.0 days in 2012 to 3.8 days in 2019 (P < .001). Hospital costs increased by $1300 from $25,730 to $27,077 (P < .001). The proportion of rTKA cases performed at urban academic centers increased (52.1% to 74.3%, P < .001) while that at urban nonacademic centers decreased (39.0% to 19.2%, P < .001). The top 3 indications for rTKA were aseptic loosening, PJI, and instability, with PJI becoming the most common indication in 2019. These cases are increasingly being performed at urban academic centers and away from urban nonacademic centers. 3 (Retrospective cohort study).

30 June 2022 in JSES International
Verified
Journal Article
Open access
SASeth Ahlquist
Seth Ahlquist
PHPeter P. Hsiue
Peter P. Hsiue
CCClark J. Chen
Clark J. Chen
BSBrendan Shi
Brendan Shi
AUAlexander Upfill-Brown
Alexander Upfill-Brown
ASAlexandra I. Stavrakis
Alexandra I. Stavrakis
Renal osteodystrophy predisposes renal disease patients to fracture. Proximal humerus fractures (PHFs) frequently undergo open reduction internal fixation (ORIF); however, the effect of renal disease on outcomes is unknown. A retrospective review of the Nationwide Readmissions Database used International Classification of Diseases, 9th Revision, codes to identify patients who underwent ORIF for closed PHF from 2010 to 2014 with no renal disease, predialysis chronic renal disease (CRD), and end-stage renal disease (ESRD). A total of 85,433 patients were identified, including 5498 (6.4%) CRD and 636 (0.7%) ESRD. CRD and ESRD patients had increased age, comorbidities, and rates of Medicare insurance. After adjusting for differences, CRD and ESRD patients were at increased risk of any complication (odds ratio [OR] 2.48, 1.66), blood transfusion (OR 1.85, 3.31), respiratory complications (OR 1.14, 1.59), acute renal failure (OR 4.80, 1.67), systemic infection (OR 2.00, 3.14), surgical site infection (OR 1.52, 3.87), longer length of stay (7.1 and 12.9 days vs. 5.9 days), and higher cost ($21,669 and $35,413 vs. $20,394) during index hospitalization, as well as surgical site infection (OR 1.43, 3.03) and readmission (OR 1.61, 3.69) within 90 days of discharge, respectively, compared with no renal disease patients. During index hospitalization, CRD patients also had increased risk for periprosthetic fracture (OR 4.97) and cardiac complications (OR 1.47), whereas ESRD patients had increased risk of mortality (OR 5.79), wound complication (2.67), and deep vein thrombosis (OR 16.70). These findings suggest renal patients are at increased risk for complications after PHF ORIF, highlighting the importance of close perioperative monitoring and appropriate patient selection in this population, including strong consideration of nonoperative management.

24 May 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
SASeth Ahlquist
Seth Ahlquist
SKSamuel T. Kim
Samuel T. Kim
PHPeter P. Hsiue
Peter P. Hsiue
AUAlexander Upfill-Brown
Alexander Upfill-Brown
CPChristos Photopoulos
Christos Photopoulos
ASAlexandra I. Stavrakis
Alexandra I. Stavrakis

19 April 2022 in HIP International
Verified
Journal Article
Closed access
SASeth Ahlquist
Seth Ahlquist
SKSamuel T Kim
Samuel T Kim
PHPeter P Hsiue
Peter P Hsiue
PBPeyman Benharash
Peyman Benharash
DPDanielle Y Ponzio
Danielle Y Ponzio
ASAlexandra I Stavrakis
Alexandra I Stavrakis
Introduction: Total hip arthroplasty (THA) in end-stage renal disease (ESRD) patients is associated with increased complications. Controversy exists whether elective THA should be performed while these patients are on haemodialysis (HD) or following renal transplant (RT). This study seeks to compare THA outcomes in HD versus RT patients. Methods: A national database was retrospectively reviewed using ICD codes to identify all HD and RT patients who underwent primary THA from 2010 to 2018. Demographics, comorbidities, and hospital factors were compared between cohorts using Wald and chi-square tests. The primary outcome was in-hospital mortality, while secondary outcomes included length of stay (LOS), non-home discharge, cost, readmission, and medical/surgical complications. Multivariate regression was used to determine independent associations. Significance was determined with a 2-tailed p-value of 0.05. Results: 11,133 patients underwent THA, 61.6% HD and 39.4% RT patients. RT patients were younger, had fewer comorbidities, and more likely to have private insurance. After adjusting for these differences, RT patients had a lower rate of mortality (OR 0.31, p = 0.01), complications (OR 0.54, p < 0.01), cardiopulmonary complications (OR 0.54, p = 0.04), sepsis (OR 0.43, p < 0.01), and blood transfusion (OR 0.39, p < 0.001) during the index hospitalisation. RT was associated with decreased LOS (−2.0 days, p < 0.001), non-home discharge (OR 0.35, p < 0.001), and hospital cost (−$6,000, p < 0.001). RT had a lower rate of readmission (OR 0.60, p < 0.001) and revision surgery (OR 0.24, p = 0.01) within 90 days. Conclusions: These findings suggest HD patients are a high-risk population in THA compared to RT patients and warrant stringent perioperative monitoring.

9 November 2022 in Seminars in Arthroplasty: JSES
Verified
Journal Article
Open access
SASeth Ahlquist
Seth Ahlquist
KCKevin Y. Chen
Kevin Y. Chen
BSBrendan Y. Shi
Brendan Y. Shi
BRBrandon Romero
Brandon Romero
JHJohn G. Horneff
John G. Horneff
CPChristos Photopoulos
Christos Photopoulos

14 June 2024 in Journal of Hand Surgery Global Online
Verified
Journal Article
Open access
SASeth Ahlquist
Seth Ahlquist
JGJordan S. Gross
Jordan S. Gross
SNScott D. Nelson
Scott D. Nelson
NBNicholas M. Bernthal
Nicholas M. Bernthal
LWLauren E. Wessel
Lauren E. Wessel
Carpal giant cell tumor of bone spanning multiple bones is a rare condition. We present a case of a man in his fifth decade with wrist pain who was found to have giant cell tumor of bone involving his capitate and hamate bones. This condition was successfully treated with intralesional curettage, argon beam coagulation, chemical cauterization and a cemented limited carpal fusion with satisfactory outcomes and no recurrence at 1-year postoperative follow-up.